Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus

Abstract

Various autoantibodies have been identified in sera from patients with systemic lupus erythematosus (SLE) and autoantibodies against neutrophil have been reported. It was suggested that antineutrophil autoantibodies might be involved in the pathogenesis of neutrocytopenia; however, the role of autoantibodies against neutrophil precursors and their specific target autoantigen(s) remained further characterized. The objective was to investigate the target antigens and clinical associations of autoantibodies against neutrophils and neutrophil precursors in patients with SLE. Sera were collected from 92 patients with SLE and renal biopsy proven lupus nephritis. Cell lysates of peripheral neutrophils (as mature neutrophils) from a normal blood donor and white blood cells from a patient with blast crisis of chronic granulocytic leukemia (CGL) (as neutrophil precursors) were used as antigens in Western blot analysis to detect autoantibodies in sera from patients with SLE. The clinical significance of antineutrophil autoantibodies that recognized different antigens were further analysed. Using normal peripheral neutrophils as antigens, two bands could be blotted: 64 kD (33/92, 35.9%) and 50 kD (13/92, 14.1%). The prevalence of anti-64 kD autoantibody in patients with positive rheumatic factor was significantly higher than that in patients without (54.5 versus 18.8%, P, 0.05). Using CGL white cells as antigen, five bands could be blotted: 60 kD (34/92, 37.0%), 50 kD (32/92, 34.8%), 29 kD (27/92, 29.3%), 42 kD (19/92, 20.7%) and 18 kD (16/92, 17.4%). The prevalence of anti-60 kD autoantibody was significantly higher in patients with neutrocytopenia than that in patients without neutrocytopenia (100 versus 48.3%, P, 0.01). The prevalence of anti-29 kD autoantibody was significantly higher in patients with alopecia than that in patients without alopecia (45.8 versus 20.8%, P, 0.05). Furthermore, the prevalences of anti-60 kD, anti-50 kD and anti-42 kD autoantibodies were significantly higher in patients with anti-Ro autoantibody than those in patients without; the prevalences of anti-29 kD and anti-18 kD autoantibodies were significantly higher in patients with anti-Sm autoantibody than those in patients without. We conclude that there are heterogeneous autoantibodies against both neutrophils and their precursors in sera from patients with SLE. Different autoantibodies may have different clinical significance.

Keywords

autoantibodies autoantigen neutrophils SLE

Get full access to this article

View all access options for this article.

References

Zhao MH , Liu N , Zhang YK , Wang HY. Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis . Nephrol Dial Transplant 1998; 13: 2821-2824 .

Spronk PE , Bootsma H , Horst G et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus . Br J Rheumatol 1996; 35: 625-631 .

Galeazzi M , Morozzi G , Sebastiani GD et al. In 566 European patients with systemic lupus erythematosus: prevalence, clinical association and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE . Clin Exp Rheumatol 1998; 16: 541-546 .

Sinico RA , Pozzi C , Radice A et al. Clinical significance of antineutrophil cytoplasmic antibodies with specificity for lactoferrin in renal disease . Am J Kidney Dis 1993; 22: 253-260 .

Fu HL , Hsu TC , Chang CC , Tsay GJ. Antigenic specificity of anti-neutrophil cytoplasmic antibody . J Formos Med Assoc 2001; 100: 35-39 .

Manolova I , Dancheva M , Halacheva K. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations . Rheumatol Int 2001; 20: 197-204 .

Chin HJ , Ahn C , Lim CS et al. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis . Am J Nephrol 2000; 20: 57-63 .

Molnar K , Kovacs L , Kiss M , Husz S , Dobozy A , Pokorny G. Antineutrophil cytoplasmic antibodies in patients with systemic lupus Erythematosus . Clin Exp Dermatol 2002; 27: 59-61 .

Lee SS , Lawton JWM , Chan CE , Li CS , Kwan TH , Chau KF. Antilactoferrin antibody in systemic lupus erythematosus . Br J Rheumatol 1992; 31: 669-673 .

10.

Chikazawa H , Nishiya K , Matsumori A , Hashimoto K. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases . J Clin Immunol 2000; 20: 279-286 .

11.

Hartman KR. Neutrophil autoantibodies. In Peter JB , Shoenfeld Y eds. Autoantibodies. Amsterdam: Elsevier Science BV , 1996: 555-560.

12.

Hartman KR , LaRussa, VF , Rothwell SW et al. Antibodies to myeloid precursor cells in autoimmune neutropenia . Blood 1994; 84: 625-631 .

13.

Kurien BT , Newland J , Paczkowski C et al. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen . Clin Exp Immunol 2000; 120: 209-217 .

14.

Kanagasegar S , Cimaz R , Kurien BT , Brucato A , Scofield RH. Neonatal lupus manifests as isolated neutropenia and mildly abnormal liver functions . J Rheumatol 2002; 29: 187-191 .

15.

Hsieh SC , Yu HS , Lin WW et al. Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus . Clin Exp Immunol 2003; 131: 506-516 .

16.

Bombardier C , Gladman DD , Urowitz MB , Caron D , Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum 1992; 35: 630-640 .

17.

van der Woude FJ , Rasmussen N , Lobatto S et al. Autoantibidies against neutrophil and monocyte: Tool for diagnosis and marker of disease activity in Wegener’s granulomatosis . Lancet 1985; 1: 425-429 .

18.

Ronit S , Jeffery L , Ralph LN et al. Organs affected by lupus erythematosus. In Lahita RG ed. Systemic lupus erythematosus. San Diego: Academic , 1999: 765-792.